Research for the molecular imaging of the PD-L1 targeting PET tracer 68Ga-WL12

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000038336

Enrollment

Unknown

Registered

2020-09-18

Start date

2019-07-01

Completion date

Unknown

Last updated

2020-12-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Solid Tumors

Interventions

case series:68Ga-WL12 PET/CT examination

Eligibility

Sex/Gender

All

Age

18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. The ECoG score was 0 or 1 in patients with age > 18 years; 2. Patients with solid tumors; 3. Patients with measurable lesions on imaging examination; 4. Patients with expected survival time >= 12 weeks.

Exclusion criteria

Exclusion criteria: 1. Patients with severe abnormal liver and kidney function; 2. Pregnant, pregnant and lactating women; 3. Patients who cannot lie on their back for half an hour; 4. Patients who refuse to join the clinical study; 5. Patients with claustrophobia or other mental disorders; 6. Other researchers think it is not suitable to participate in the experiment.

Design outcomes

Primary

Measure	Time frame
SUV/SUL;	—

Countries

China

Contacts

Public ContactZhu Hua

Beijing Cancer Hospital

zhuhuananjing@163.com+86 10-88196495

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026